Molnupiravir Impurity and USP Related Compound

Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Molnupiravir is used by adults 18 years of age and older who have had mild to moderate symptoms for no more than 5 days and are not hospitalized. Molnupiravir Degradation impurity, Molnupiravir Process impurity, Molnupiravir Potential impurity, Molnupiravir USP Related Compound, Molnupiravir N-Nitroso impurity, Molnupiravir nitrosamine impurity etc. are listed below